蔓越通过调节AMPK/SREBP1,ROCK1和TGF-β1来改善与代谢综合征相关的老鼠器官功能障碍
Sahar M Elashmony1, Yosra Alhindi2, Dina H Merzeban3
1Medical Pharmacology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Scientific reports
|September 15, 2025
概括
蔓越提取物通过改善关键健康标志物和保护器官,在治疗代谢综合征 (MetS) 中表现有前途. 它的效果与甲福明相似,这表明它是一种安全,天然的治疗方法.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 病理学 病理学 病理学
背景情况:
- 代谢综合征 (MetS) 是一个重大的全球健康挑战,增加医疗保健成本和降低生活质量.
- 迫切需要 MetS 的有效预防和管理策略.
研究的目的:
- 为了研究蔓越提取物 (Vaccinium macrocarpon) 和甲胺在MetS.的老鼠模型中的治疗潜力.
- 评估蔓越和甲胺对代谢参数,器官病理和与MetS相关的分子途径的影响.
主要方法:
- 通过使用高脂肪和高果糖饮食,然后注射 estreptozotocin,建立了MetS的老鼠模型.
- 鼠被用不同剂量的蔓越提取物或甲胺治疗了四周.
- 评估包括代谢分析,器官组织病理学,以及基因表达 (Rock1,Srebf1) 和蛋白质标记物 (iNOS,TGF-β1) 的分析.
主要成果:
- 引发MetS导致体重增加,BMI,葡萄糖不耐受,脂质不良,肌氨酸升高和高血压.
- 观察到肝脏和脏结构异常,以及原和iNOS/TGF-β1表达的增加.
- 蔓越提取物剂量依赖地改善了代谢参数,上调AMPK,下调Rock1和Srebf1,改善了器官损伤,并减少了iNOS/TGF-β1表达,结果与甲胺相当.
结论:
- 蔓越提取物显示出对管理MetS的显著治疗潜力.
- 它提供了广泛的益处,包括器官保护和关键分子通路的调制.
- 蔓越提取物代表了一种有希望的,安全的,自然的替代物,用于MetS管理.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
922
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
599
相关概念视频
Global Regulatory Systems
612
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
612
cAMP-dependent Protein Kinase Pathways
8.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.3K
Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
